Literature DB >> 15728172

The case for randomized trials in cancer treatment: new is not always better.

Alison Grann, Victor R Grann.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15728172     DOI： 10.1001/jama.293.8.1001

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.

Authors:  Benjamin Djulbegovic; Ambuj Kumar; Heloisa P Soares; Iztok Hozo; Gerold Bepler; Mike Clarke; Charles L Bennett
Journal:  Arch Intern Med       Date:  2008-03-24

2.  Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Authors:  John A Chabot; Wei-Yann Tsai; Robert L Fine; Chunxia Chen; Carolyn K Kumah; Karen A Antman; Victor R Grann
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

3.  A social network analysis of treatment discoveries in cancer.

Authors:  Athanasios Tsalatsanis; Laura Barnes; Iztok Hozo; John Skvoretz; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.